“The goal is for all the children in the world to overcome a cancer that has a cure: retinoblastoma” Guillermo Luís Chantada, oncologist and haematologist at SJD Barcelona Children’s Hospital explains his work in research and treatment for retino...
The Spinal Unit combines intraoperative CT and neuronavigation in complex surgeries The new SJD Barcelona Children's Hospital surgical block and its hybrid operating theatre enable the use of these techniques in cases of complex ...
Tips on mask use for children Face masks are an important tool, find out the types of mask that children can use.
More than 2,000 summer campers are participating in the Kids Corona study to analyse the transmissibility of COVID-19 For 5 weeks, 1,700 children and 400 camp counsellors have participated in this analysis on the behaviour of the SARS-CoV-2 virus.
YEAH project will focus on developing an education toolkit with youngsters to learn about health research Sant Joan de Déu Barcelona Children's Hospital established its own KIDS Barcelona YPAG in 2015.
SJD Barcelona Children's Hospital contributes to European research on systemic autoinflammatory diseases The Hospital is a part of the ImmunAID project, which seeks to identify new tools for the diagnosis and management of these rare diseases.
More than 14 million raised in donations to build Europe’s biggest childhood cancer centre in Barcelona Those in charge of the project announce that they will start work during the first four months of 2018
“They proposed the epilepsy surgery to us after Gara had more than 60 seizures in one day” The surgery, performed by the neurosurgeons Jordi Rumià and Santiago Candela, put an end to the teenager’s refractory epilepsy.
"It is important to stop retinoblastoma from progressing to prevent risk to the patient's life" The oncologist Genoveva Correa talks about the first patient to be officially treated by the Pediatric Cancer Center Barcelona, a case of retinobl...
Researchers from SJD Barcelona Children’s Hospital discover a treatment for the most common CDG The drug has been on the market since the 1950s, costs two euros and is indicated for altitude sickness, heart failure and glaucoma
